Physician Assistant in Idaho Falls, ID Accepting Medicare
124 Physician Assistant nurses found. Showing 121 - 124
 Mr. Joshua Phillip Black, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 740 S Woodruff Ave, Idaho Falls, ID 83401 Phone: 208-542-9111 |
William Scott Ulrich, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1550 Elk Creek Dr, Idaho Falls, ID 83404 Phone: 208-529-5942 Fax: 208-529-5951 |
 Melissa D Bates, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 808 Pancheri Dr, Idaho Falls, ID 93402 Phone: 208-552-6900 Fax: 208-552-4973 |
Benjamin Jacob Johnson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3200 Channing Way Ste 206, Idaho Falls, ID 83404 Phone: 208-529-2230 Fax: 208-453-6142 |
News Archive
60% of pregnant women never tested for CHD
Three out of five women who have given birth to a child with a congenital heart defect (CHD) - the number-one birth defect and leading killer of infants and newborns - were never tested for the defect during pregnancy. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.
Intermediate embryonic stem cell type could lead to advances in regenerative medicine
A team led by UT Southwestern has derived a new "intermediate" embryonic stem cell type from multiple species that can contribute to chimeras and create precursors to sperm and eggs in a culture dish.
Exercise cuts colon cancer risk by a quarter
Engaging in physical activity can reduce your chances of developing the most common kind of bowel cancer by a quarter, according to new research published in the British Journal of Cancer.
Four-year follow-up results from SPRYCEL Phase 3 study in CML-CP presented at ASCO
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced four-year follow-up results from a Phase 3 randomized, open-label, dose-optimization study of SPRYCEL® (dasatinib) in chronic-phase chronic myeloid leukemia (CML-CP) patients resistant or intolerant to Gleevec®* (imatinib mesylate). At four years, for all patients administered SPRYCEL 100 mg once daily, overall survival was 82% (95% CI: 76%-88%) and progression-free survival was 66% (95% CI: 57%-74%).
Researchers use nanofactories to prevent bacteria without using antibiotics
New research at the A. James Clark School of Engineering could prevent bacterial infections using tiny biochemical machines—nanofactories—that can confuse bacteria and stop them from spreading, without the use of antibiotics.
› Verified 3 days ago
Nurse Practitioner
Physician Assistant
Registered Nurse
Nurse Anesthetist - CR